LACRISTENT Trademark

Trademark Overview

On Tuesday, February 4, 2020, a trademark application was filed for LACRISTENT with the United States Patent and Trademark Office. The USPTO has given the LACRISTENT trademark a serial number of 88784088. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 10, 2023. This trademark is owned by Quest Medical, Inc.. The LACRISTENT trademark is filed in the Medical Instrument Products category with the following description:

Medical device, namely, a monocanalicular stent
lacristent

General Information

Serial Number88784088
Word MarkLACRISTENT
Filing DateTuesday, February 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements

Pseudo MarkLACRI STENT
Goods and ServicesMedical device, namely, a monocanalicular stent

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 7, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuest Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAllen, TX 75002
Party NameQuest Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAllen, TX 75002

Trademark Events

Event DateEvent Description
Monday, July 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU EXTENSION 5 GRANTED
Monday, November 28, 2022SOU EXTENSION 5 FILED
Tuesday, December 6, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Saturday, June 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2022SOU EXTENSION 4 GRANTED
Thursday, June 9, 2022SOU EXTENSION 4 FILED
Thursday, June 9, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 3 GRANTED
Monday, December 6, 2021SOU EXTENSION 3 FILED
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Friday, June 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 9, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 9, 2021SOU EXTENSION 2 FILED
Wednesday, June 9, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020SOU EXTENSION 1 GRANTED
Wednesday, December 9, 2020SOU EXTENSION 1 FILED
Wednesday, December 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2020ASSIGNED TO EXAMINER
Friday, February 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 7, 2020NEW APPLICATION ENTERED

Related Keywords

lacristent stent monocanalicular namely device medical